Cargando…

Minimum effective volume of 0.2% ropivacaine for ultrasound-guided axillary brachial plexus block in preschool-age children

Ultrasound-guided axillary brachial plexus block is increasingly used in preschool-age patients. However, the minimum effective volume of local anaesthetics has not been determined. With ethical committee approval and written informed consent from the guardians of all paediatric patients, we studied...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Liang, Shen, Yang, Liu, Shuangmei, Cao, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379224/
https://www.ncbi.nlm.nih.gov/pubmed/34417524
http://dx.doi.org/10.1038/s41598-021-96582-3
_version_ 1783740965593284608
author Chen, Liang
Shen, Yang
Liu, Shuangmei
Cao, Yanyan
author_facet Chen, Liang
Shen, Yang
Liu, Shuangmei
Cao, Yanyan
author_sort Chen, Liang
collection PubMed
description Ultrasound-guided axillary brachial plexus block is increasingly used in preschool-age patients. However, the minimum effective volume of local anaesthetics has not been determined. With ethical committee approval and written informed consent from the guardians of all paediatric patients, we studied 27 consecutive patients aged 3 to 6 years who were scheduled for hand surgery. After general anaesthesia, eligible patients received a set volume of ultrasound-guided axillary brachial plexus block. We determined the volume of 0.2% ropivacaine for consecutive patients from the preceding patient’s outcome. The initial volume was 0.4 ml/kg. The testing interval was set at 0.05 ml/kg, and the lowest volume was 0.1 ml/kg. The following conditions were defined as a successful block: no heart rate changes, body movement, or ventilatory disorders during the operation; no use of fentanyl in the PACU; and a postoperative sensory block score < 3. The sequences of positive and negative blocks in consecutive patients were recorded. Using probit regression analysis, the 50% effective volume was 0.185 ml/kg (95% CI 0.123–0.234), and the 95% effective volume was 0.280 ml/kg (95% CI 0.232–0.593). EV50 and EV95 values of 0.2% ropivacaine for ultrasound-guided axillary brachial plexus block were 0.185 ml/kg and 0.280 ml/kg, respectively.
format Online
Article
Text
id pubmed-8379224
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-83792242021-08-27 Minimum effective volume of 0.2% ropivacaine for ultrasound-guided axillary brachial plexus block in preschool-age children Chen, Liang Shen, Yang Liu, Shuangmei Cao, Yanyan Sci Rep Article Ultrasound-guided axillary brachial plexus block is increasingly used in preschool-age patients. However, the minimum effective volume of local anaesthetics has not been determined. With ethical committee approval and written informed consent from the guardians of all paediatric patients, we studied 27 consecutive patients aged 3 to 6 years who were scheduled for hand surgery. After general anaesthesia, eligible patients received a set volume of ultrasound-guided axillary brachial plexus block. We determined the volume of 0.2% ropivacaine for consecutive patients from the preceding patient’s outcome. The initial volume was 0.4 ml/kg. The testing interval was set at 0.05 ml/kg, and the lowest volume was 0.1 ml/kg. The following conditions were defined as a successful block: no heart rate changes, body movement, or ventilatory disorders during the operation; no use of fentanyl in the PACU; and a postoperative sensory block score < 3. The sequences of positive and negative blocks in consecutive patients were recorded. Using probit regression analysis, the 50% effective volume was 0.185 ml/kg (95% CI 0.123–0.234), and the 95% effective volume was 0.280 ml/kg (95% CI 0.232–0.593). EV50 and EV95 values of 0.2% ropivacaine for ultrasound-guided axillary brachial plexus block were 0.185 ml/kg and 0.280 ml/kg, respectively. Nature Publishing Group UK 2021-08-20 /pmc/articles/PMC8379224/ /pubmed/34417524 http://dx.doi.org/10.1038/s41598-021-96582-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Chen, Liang
Shen, Yang
Liu, Shuangmei
Cao, Yanyan
Minimum effective volume of 0.2% ropivacaine for ultrasound-guided axillary brachial plexus block in preschool-age children
title Minimum effective volume of 0.2% ropivacaine for ultrasound-guided axillary brachial plexus block in preschool-age children
title_full Minimum effective volume of 0.2% ropivacaine for ultrasound-guided axillary brachial plexus block in preschool-age children
title_fullStr Minimum effective volume of 0.2% ropivacaine for ultrasound-guided axillary brachial plexus block in preschool-age children
title_full_unstemmed Minimum effective volume of 0.2% ropivacaine for ultrasound-guided axillary brachial plexus block in preschool-age children
title_short Minimum effective volume of 0.2% ropivacaine for ultrasound-guided axillary brachial plexus block in preschool-age children
title_sort minimum effective volume of 0.2% ropivacaine for ultrasound-guided axillary brachial plexus block in preschool-age children
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379224/
https://www.ncbi.nlm.nih.gov/pubmed/34417524
http://dx.doi.org/10.1038/s41598-021-96582-3
work_keys_str_mv AT chenliang minimumeffectivevolumeof02ropivacaineforultrasoundguidedaxillarybrachialplexusblockinpreschoolagechildren
AT shenyang minimumeffectivevolumeof02ropivacaineforultrasoundguidedaxillarybrachialplexusblockinpreschoolagechildren
AT liushuangmei minimumeffectivevolumeof02ropivacaineforultrasoundguidedaxillarybrachialplexusblockinpreschoolagechildren
AT caoyanyan minimumeffectivevolumeof02ropivacaineforultrasoundguidedaxillarybrachialplexusblockinpreschoolagechildren